- Home
- / Hangzhou Bio-Sincerity Pharma-Tech
Hangzhou Bio-Sincerity Pharma-Tech
Stock Price
¥40.9
2024-10-29
Market Capitalization
¥4.3 B
2024-10-29
Revenue
¥672.3 M
FY, 2025
Hangzhou Bio-Sincerity Pharma-Tech Summary
Company Summary
- Overview
- Hangzhou Bio-Sincerity Pharma-Tech (杭州百诚医药科技股份有限公司) is a company that develops pharmaceutical solutions. It offers drug discovery, pharmaceutical research, clinical trials, registration application, etc.
- Type
- Public
- Status
- Active
- Founded
- 2011
- Website
- https://www.hzbio-s.com/
- Cybersecurity rating
Table of Contents
Hangzhou Bio-Sincerity Pharma-Tech Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥157.9M
- Gross profit (Q1, 2026)
- ¥78.5M
- Net income (Q1, 2026)
- ¥12.8M
- Cash (Q1, 2026)
- ¥396.5M
- EBIT (Q1, 2026)
- ¥16.9M
- Enterprise value
- $4.9B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026